BeyondSpring, Inc.
做多

BYSI BeyondSpring Price Target

692
BYSI BeyondSpring drug, plinabulin, increased overall survival and improved other measures of disease while staving off a dangerous side effect associated with Chemotherapy.

BeyondSpring is preparing to ask for plinabulin approval in the U.S. and China.

On 8/4/2021 J. Pantginis from HC Wainwright brokerage Upgraded BYSI BeyondSpring from Neutral to Buy giving a Price Target of $100.00

My price target is the all time high resistance of 48usd until we hear some news from the FDA.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。